1. Home
  2. LXRX vs NX Comparison

LXRX vs NX Comparison

Compare LXRX & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.31

Market Cap

541.5M

Sector

Health Care

ML Signal

HOLD

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$16.45

Market Cap

599.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXRX
NX
Founded
1995
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
541.5M
599.2M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
LXRX
NX
Price
$1.31
$16.45
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$3.23
N/A
AVG Volume (30 Days)
1.4M
906.3K
Earning Date
11-06-2025
12-11-2025
Dividend Yield
N/A
1.94%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,864,000.00
$1,837,641,000.00
Revenue This Year
$56.61
$46.73
Revenue Next Year
N/A
$0.48
P/E Ratio
N/A
N/A
Revenue Growth
1255.21
43.81
52 Week Low
$0.28
$11.04
52 Week High
$1.66
$29.67

Technical Indicators

Market Signals
Indicator
LXRX
NX
Relative Strength Index (RSI) 43.02 76.88
Support Level $1.29 $13.18
Resistance Level $1.48 $14.11
Average True Range (ATR) 0.07 0.84
MACD -0.01 0.42
Stochastic Oscillator 10.53 55.16

Price Performance

Historical Comparison
LXRX
NX

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: